Free Trial

Medical Properties Trust (NYSE:MPW) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Medical Properties Trust logo with Finance background

Medical Properties Trust (NYSE:MPW - Get Free Report) posted its quarterly earnings data on Thursday. The real estate investment trust reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.02, Zacks reports. The firm had revenue of $231.84 million for the quarter, compared to the consensus estimate of $218.77 million.

Medical Properties Trust Stock Down 2.0 %

Shares of Medical Properties Trust stock traded down $0.12 on Monday, hitting $5.78. The company had a trading volume of 24,301,605 shares, compared to its average volume of 13,410,753. Medical Properties Trust has a 1 year low of $3.51 and a 1 year high of $6.55. The company has a debt-to-equity ratio of 1.69, a quick ratio of 2.38 and a current ratio of 2.38. The stock has a 50 day moving average of $4.44 and a 200-day moving average of $4.66. The stock has a market capitalization of $3.47 billion, a price-to-earnings ratio of -1.37, a P/E/G ratio of 1.01 and a beta of 1.32.

Medical Properties Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 10th will be issued a $0.08 dividend. The ex-dividend date is Monday, March 10th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 5.54%. Medical Properties Trust's dividend payout ratio is presently -7.58%.

Insider Activity at Medical Properties Trust

In other news, CAO James Kevin Hanna sold 11,641 shares of the firm's stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $3.72, for a total transaction of $43,304.52. Following the completion of the sale, the chief accounting officer now directly owns 366,913 shares of the company's stock, valued at $1,364,916.36. This trade represents a 3.08 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.53% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have issued reports on MPW shares. Truist Financial cut their price objective on shares of Medical Properties Trust from $6.00 to $4.00 and set a "hold" rating for the company in a report on Thursday, December 19th. Mizuho dropped their price target on shares of Medical Properties Trust from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Thursday, December 5th. Finally, StockNews.com raised Medical Properties Trust from a "sell" rating to a "hold" rating in a research report on Monday. Seven analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Medical Properties Trust has an average rating of "Hold" and an average price target of $4.92.

Read Our Latest Research Report on Medical Properties Trust

About Medical Properties Trust

(Get Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Featured Stories

Earnings History for Medical Properties Trust (NYSE:MPW)

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines